Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01671761 · ClinicalTrials.gov registry record

Normative Data of Brain Network Activation in Adolescents and Young Adults

A clinical trial of Healthy (Controls), sponsored by ElMindA.

Completed
Registry status
43
Enrollment target
1
Study location

NCT01671761: Completed study of Healthy (Controls), sponsored by ElMindA.

NCT01671761 is a study of Healthy (Controls) that has completed, run by ElMindA. The registered enrollment target is 43 participants, below the 118-participant average among 16 other Healthy (Controls) trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01671761, a study of Healthy (Controls), has completed, sponsored by ElMindA.

COMPLETED
Registry status
43 participants
Enrollment target
1
Study location

Study Summary

Establish normative data of ElMindA's Brain Network Activation (BNA) using evoked response in two age groups: adolescents and young adults.

Primary Outcome

The study outcome measure are functional networks of brain activity of healthy adolescents (age 15-18 years) and young adults (19-24 years) established based on an analysis of EEG data recorded while study subjects perform ERP tasks

Conditions Studied

Study Locations (1)

New York

  • Clinilabs, Inc. - New York

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2012-08
Est. Completion 2014-07
ElMindA

12 total trials

What the finished NCT01671761 record still lists

NCT01671761 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 118-participant average among 16 other Healthy (Controls) trials with a reported enrollment target (64% lower).

The record links to 1 condition, with Healthy (Controls) appearing as the primary indexed condition, and to 0 interventions.

NCT01671761 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01671761 about?

NCT01671761 is a clinical study titled "Normative Data of Brain Network Activation in Adolescents and Young Adults". Establish normative data of ElMindA's Brain Network Activation (BNA) using evoked response in two age groups: adolescents and young adults.

What is the current status of trial NCT01671761?

This trial is currently completed. The enrollment target is 43 participants. The study started on 2012-08. Estimated completion is 2014-07.

What conditions does trial NCT01671761 study?

This clinical trial studies the following conditions: Healthy (Controls).

Who is sponsoring clinical trial NCT01671761?

This trial is sponsored by ElMindA, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01671761 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy (Controls)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01671761's enrollment target sits among peer trials

43 13th of 16 higher than 4 of 16 other Healthy (Controls) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy (Controls) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01671761, the US trial registry maintained by the National Library of Medicine. NCT01671761 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.